Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3279 of 6351
-
New drug INCB123667 enters human trials for Hard-to-Treat cancers
Disease control OngoingThis is an open-label, dose-escalation and dose-expansion study to determine the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of INCB123667 when administered as monotherapy and in combination with anticancer therapies in participants with selected advanced…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug combo shows promise in early brain cancer trial
Disease control CompletedThis study will evaluate the addition of regorafenib to standard of care treatment with TMZ as adjuvant therapy, and in combination with TMZ+RT as concomitant therapy. The standard of care for newly diagnosed GBM (ndGBM) includes surgical resection to the extent that is safely f…
Phase 1 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Pharmacists step in to tame uncontrolled diabetes
Disease control OngoingType 2 diabetes is a chronic disease that can lead to a number of complications if uncontrolled and there is a projected increase of 33% patients living with diabetes over the next 10 years. There can be improvements to modifiable risk factors such as diet and exercise, in additi…
Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study tests coaching program to help mentally ill reclaim their lives
Symptom relief Recruiting nowThis study tests an intervention that uses health coaching, motivational interviewing, positive psychology, and online wellness tools to help adults with mental illness return to active lives after major disruptions such as the COVID-19 pandemic.
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 26, 2026 17:14 UTC
-
Can amino acids help anorexia patients regain muscle?
Disease control Recruiting nowAmino acids (AAs) are crucial for protein synthesis, in influencing nutritional status, as sources of vital elements (e.g., nucleotides, neurotransmitters) and as signal molecules for the modulation of gene expression and epigenetic mechanisms. Data on the role of amino acids in …
Sponsor: Villa Garda Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:45 UTC
-
2,300 COVID survivors join quest to unravel long COVID mysteries
Knowledge-focused Recruiting nowThe EuCARE-POSTCOVID study is an observational multicentre study enrolling COVID-19 patients recovered from the acute phase of disease to investigate the prevalence and possible predictors of post COVID-19 condition. The study will retrospectively analyze data already collected a…
Sponsor: Euresist Network GEIE • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:08 UTC
-
New oxygen technique may keep lungs safe after throat surgery
Prevention CompletedPatients undergoing major head and neck surgery are at risk for postoperative pulmonary complications. The goal of this randomized clinical trial is to evaluate the effectiveness of high flow heated humidified oxygen at preventing postoperative pulmonary complications after major…
Sponsor: University of Florida • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
Family-Powered rehab app may boost ICU sleep and cut stigma
Symptom relief CompletedThis prospective, randomized controlled trial aims to evaluate the efficacy of an Internet-Based, Family-Participatory Early Rehabilitation (IFPER) model compared to standard care for critically ill patients in the Intensive Care Unit (ICU). The study will determine if the IFPER …
Sponsor: The First Hospital of Hebei Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for glioblastoma? early trial tests tinostamustine
Disease control CompletedThe study is designed as an open label, multi-center, Phase 1 study of single agent tinostamustine, used as adjuvant treatment in patients with newly diagnosed GBM who are MGMT unmethylated and have completed concomitant treatment with temozolomide and radiation. Treatment with a…
Early phase 1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New registry aims to find best blood thinner combo for rare clotting disorder
Disease control Recruiting nowThe goal of this registry is to gather more information on the efficacy and safety of various antithrombotic regimens. The registry collects data on patients with antiphospholipid syndrome and an arterial event within the past 12 months, on treatment with either A) a VKA with the…
Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Online sleep program could help TBI patients get better rest
Symptom relief Recruiting nowSleep disturbance is a common condition following traumatic brain injury (TBI) and impairs recovery and quality of life. While efficacious interventions exist many are not accessible to all patients due to a variety of factors (e.g., rurality, access to providers). Further, many …
Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Patient's own immune cells plus drug tested against tough melanoma
Disease control OngoingThis phase I/II trial tests the safety and side effects of LN-144 (Lifileucel) and pembrolizumab in treating patients with stage IIIB-D or stage IV melanoma that has spread to nearby tissue or lymph nodes. Biological therapies, such as LN-144 (Lifileucel), use substances made fro…
Phase 1 • Sponsor: Richard Wu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Veterans' heart failure study tests simple knee exercise fix
Knowledge-focused Recruiting nowHeart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity a…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New hope for IgG4 patients: which drug combo works best?
Disease control Recruiting nowThis study has been designed as a 12-month, open-label randomized controlled clinical trial. The study aims to compare the efficacy and safety of two treatment strategies in IgG4-RD patients with superficial organ involvement: prednisone plus iguratimod and prednisone plus leflun…
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Step by step: walking program shows promise for lupus fatigue
Symptom relief CompletedBackground: Fatigue is a major concern to individuals with lupus, persisting even when disease activity is clinically minimal, and impacting almost all quality of life domains. Studies show cross-sectional correlations between fatigue and physical activity levels in lupus. Some p…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can magnetic pulses ease nerve pain in spinal injury?
Symptom relief CompletedNeuropathic pain is a common complication after spinal cord injury (SCI), which significantly affects the patient's quality of life and may be resistant to pharmacological treatment. In our study, we aimed to evaluate the efficacies of intermittent theta burst (iTBS) and high fre…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Vitamin B12 boosts diabetes Drug's power in new study
Disease control CompletedThe current study was conducted to evaluate the prognostic implications of vitamin B12 admission on BMI and HbA1c levels in type 2 diabetic patients treated with Dapagliflozin as a routine medication.
Sponsor: Al-Balqa Applied University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Fatigue in MS might be caused by low antibodies – new study investigates
Knowledge-focused Recruiting nowThe investigators hypothesize that hypogammaglobulinemia (defined as IgG serum concentration \<7.0g/L) is a treatable cause of fatigue in people with MS: The primary objective is to prove the link between hypogammaglobulinemia and fatigue in patients with multiple sclerosis. Th…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Flaxseed oil shows promise for blood sugar control
Disease control CompletedThe findings of previous experiments suggested that alpha linolenic acid (ALA) has been linked to anti-hyperglycemic, and reducing the risk of diabetes.This is a randomized double-blind cross-over trial, aims to study the effect of ALA on glycemic status and human metabolism. Fir…
Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Fasting diet shows promise for depression in bowel disease
Symptom relief CompletedInflammatory bowel disease (IBD) is a chronic illness characterized by inflammation of the intestine. Many individuals with IBD suffer from depressive symptoms and anxiety which can lead to a decreased quality of life, poor treatment compliance, and higher morbidity and mortality…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 26, 2026 16:34 UTC